newsfilter
← Latest News
Business Wire·

Biocept Reports 2022 Financial Results

Biocept, Inc. (NASDAQ:BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the 12 months ended December 31, 2022 and provides a business update. "I could not